Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Belviq XR in combination with lifestyle modification for obesity in adolescents; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Belviq XR (lorcaserin hydrochloride extended-release (Belviq XR))

Snippet

Sponsor: Eisai Inc. | Conditions: Obesity | Phase 4 | Status: TERMINATED | Results posted: 2021-07-19